Colobomas are a type of eye defect characterized by the presence of a hole in certain eye structures. In this study, the roles of the zebrafish Otx genes, otx2 and otx1a, as well as the Rx family gene, rx3, in choroid fissure closure, the disruption of which leads to the onset of colobomas, were studied. It was observed that while the otx2 loss-of-function mutant, otx2hu3237 displayed small colobomas and the otx1a mutant, otx1a6del, did not exhibit any morphological eye defects, zebrafish possessing both mutations presented with a range of colobomas, some of which were more severe than otx2 single mutants and the size of the coloboma corresponded with the gene dosage of otx1a. Furthermore, it was also observed that additional knockdown of otx1b using morpholinos worsened the coloboma phenotype. Moreover, it was observed that rx3, while involved in RPE pigmentation, does not contribute to choroid fissure closure. Additionally, it appears that otx2 does not affect the rudimentary lens formation which is seen in loss-of-function rx3 mutants, i.e., eyeless mutants.

In the developing embryo, the timely fusion of opposing epithelial sheets into one uniform layer denotes the completion of several developmental events. Failure of this epithelial sheet fusion event (ESF) within the choroid fissure (CF) is associated with the congenital disorder Ocular Coloboma, and is one of the leading causes of pediatric blindness. A requirement for a highly coordinated dismantling of the basement membrane (BM) to allow for fusion to occur is undoubted, however the underlying mechanisms of this process are poorly understood. Due to its BM crosslinking capabilities, I have hypothesized that the regulation of nidogen plays a crucial role in the disassembly of the BM prior to ESF. Whole mount in situ hybridization for all four BM components has revealed that expression of nidogen decreases prior to that of other BM components. Additionally, preliminary IHC data has revealed nidogen and collagenIV deposition within the CF. Further, knock-down of nidogen1a and 1b, or the expression of dominant negative nidogen1b resulted in gross morphological, as well as BM organization defects in developing eyes. Together, these data suggest that nidogen plays a role in regulating the integrity of the BM of the eye and may play a role in its disassembly prior to ESF.

During optic cup morphogenesis, the neuroectodermal layers of the optic vesicle (OV) invaginate ventrally, and fuse at the choroid fissure (CF) along the proximo-distal axis such that the retina and retinal pigment epithelium (RPE) are confined within the cup. Failure of CF closure results in colobomas, which are characterized by the persistence of a cleft or hole at the back of the eye. While CF closure is a critical aspect of ocular development, the molecular and cellular mechanisms underlying this process are poorly understood. My research examined CF closure and colobomas using zebrafish as a model system. In the first study, I determined that early cell fate changes within the eye field could cause colobomas using the zebrafish mutant blowout. Colobomas in blowout resulted from defects in optic stalk morphogenesis whereby the optic stalk extended into the retina and impeded the edges of the CF from meeting and fusing. Positional cloning of blowout identified a nonsense mutation in patched1, a negative regulator of the Hedgehog pathway. Up-regulation of Hedgehog pathway activity causes disruption in the patterning of the OV into proximal and distal territories, revealing that cell fate determination, mediated by Hedgehog signaling, is intimately involved in regulating CF closure. In the second study, I examined Bcl6 function and regulation during zebrafish eye development. bcl6 encodes a transcriptional repressor expressed in the ventral retina during zebrafish eye development. Loss of Bcl6 function leads to colobomas along with up-regulation of p53, a previously known Bcl6 target, and an increase in the number of apoptotic cells in the retina, demonstrating that Bcl6 plays a critical role in preventing apoptosis in the retina during early eye development. I also showed that Vax1 and Vax2 act upstream of bcl6 in the ventral retina. Furthermore, I identified functional interactions between Bcl6, Bcor and Hdac1 during eye development, demonstrating that Bcl6 functions along with Bcor and Hdac1 to mediate cell survival by regulating p53 expression. Together my studies expand the gene regulatory network involved in cell fate determination and cell survival during CF closure and ventral retina formation, and provide mechanistic insight into coloboma formation. / text

The development of the vertebrate eye is tightly controlled by precise genetic regulations. From a single ocular primordium to bilateral eyes with complex structures and cell types, it requires intensive proliferation and migration for cells in both the ectoderm and mesoderm to accomplish ocular morphogenesis, and during this process cell differentiation and interaction takes place to establish the complex composition of ocular cell types and cellular connections. Genetic defects can lead to severe abnormalities in eye morphogenesis and cell differentiation during ocular development. A tremendous amount of work has been done to identify both intrinsic and extrinsic factors that regulate ocular development. However, much more work is needed to fully understand this complex process. Sox4 is known as a transcription activator that regulates cell survival and differentiation in multiple embryonic tissues during development. Evidence of its requirement during ocular development has recently emerged, but the mechanism by which Sox4 regulates ocular development is far from elucidated. Chapter 1 of this dissertation provides an overview of different stages in embryonic eye development and known genetic interactions during each stage. It also reviews recent knowledge about SoxC proteins and their roles in ocular development. Chapter 2 presents data characterizing the expression profile of the zebrafish sox4 co-orthologs, sox4a and sox4b, in the developing eye. Additionally, it presents data from morpholino-mediated sox4 knockdown in zebrafish, which indicate that Sox4 deficiency leads to defects in choroid fissure closure through elevation in the Hedgehog (Hh) signaling pathway. Sox4 knockdown causes upregulation of the Hh ligand indian hedgehog b (ihhb), which alters the proximal-distal boundary of the optic vesicle and inhibits choroid fissure closure. Chapter 3 presents data reporting the generation of sox4 mutant zebrafish lines using the CRISPR/Cas9 genome editing system. Characterization of one sox4a maternal zygotic (MZ) mutant line confirms Sox4’s role in negative regulation of Hh signaling and reveals new evidence that maternal and zygotic sox4 are both critical for ocular development. Chapter 4 presents data demonstrating that sox4 is required for rod photoreceptor neurogenesis. Rod photoreceptor terminal differentiation is delayed in both sox4 morphants and sox4 CRISPR mutants, while rod progenitor and precursor cells are properly specified. In Chapter 5, the roles of Sox4 in regulating ocular development are summarized based on the results, and implications of the results are discussed to expand our understanding of the genetic regulation of ocular morphogenesis and retinal neurogenesis.

Microphthalmia, anophthalmia, and coloboma (MAC) are distinct abnormalities demonstrating a continuum of developmental eye defects that contribute to 15-20% of blindness and severe vision deficiencies in children worldwide. The genetic etiology of MAC is large, complex and encompasses the whole developmental biology of the eye. Understanding how the eye develops will aid in identifying genes and developmental pathways involved in MAC. Although investigation of the genetic architecture of congenital anomalies is growing exponentially, much work remains to be accomplished to understand the complex, genetically heterogeneous congenital anomalies, which significantly impact childhood vision. With an interest in elucidating the mechanisms that are involved in eye morphogenesis, I have characterized a SRY-Box transcription factor, Sox11, during zebrafish ocular development. The SRY (sex determining region Y)-box 11 (sox11) gene, codes for a transcription factor which functions as a regulator of cell fate, survival, and differentiation in the embryonic and adult nervous system. By titrating the levels of sox11 gene function in developing zebrafish embryos I have investigated the role of Sox11 during ocular morphogenesis and retinal neurogenesis. Chapter 1 of this dissertation provides a review of vertebrate eye development with a focus on emerging roles of SoxC proteins during vertebrate ocular morphogenesis. Chapter 2 presents data demonstrating that knockdown of both paralogs of sox11 in zebrafish results in microphthalmia, coloboma, as well as a specific deficit in mature rod photoreceptors. Additionally, we demonstrate for the first time that Sox11 regulates early ocular and photoreceptor development in part by maintaining proper levels of Hedgehog (Hh) signaling. Deficiency of Sox11 results in elevated Sonic Hedgehog a (Shha) transcript levels, which in turn leads to improper patterning of the optic vesicle into the proxio-distal territories. Furthermore, the data indicate that alterations in SOX11 gene dosage or mutation within the SOX11 coding region are potentially disease causing and contribute to human ocular defects like MAC and rod dysfunction. Chapter 3 presents data indicating that sox11 gene function is required during the critical period of neurulation (4-10 hours post fertilization) to guide choroid fissure closure and proper ocular morphogenesis to occur in the developing zebrafish. Chapter 4 is a technical report on the progress towards generating stable sox11a/b knockout zebrafish lines using the CRISPR/Cas9 genome editing approach. Transient F0 injected embryos and F0 adults carry mutations in the sox11a/b target site in addition to displaying ocular abnormalities similar to those previously reported in sox11 morphants. F1 juveniles are ready to be screened for establishment of mutagenesis efficiency and germ line transmission. Finally, in Chapter 5 I discuss how the results of each chapter demonstrate the functional requirement of Sox11 for ocular development. Furthermore, I discuss the implications of this work in the field of developmental biology and how the current data will shape future investigations. My dissertation incorporates human genetics, biochemical analyses, and zebrafish reverse genetic analyses, and will help in better understanding the exact role of Sox11 during eye development at the cellular and molecular level. Moreover, by identifying Sox11 targets belonging to the Hh pathway, as well as novel targets of Sox11 regulation, these studies may also contribute to our understanding of the function of Sox11in development and disease pathogenesis.

L’ataxie spinocérébelleuse de type 7 (SCA7) est une maladie neurodégénérative à transmission autosomale dominante, causée par une expansion toxique de polyglutamine (polyQ) dans la protéine Ataxine-7. Elle se caractérise par une dégénérescence des photorécepteurs en cônes et en bâtonnets, ainsi que des cellules cérébelleuses de Purkinje et granuleuses. La nature sélective de cette dégénérescence reste peu claire, l’expression d’Ataxine-7 étant ubiquitaire. Dans ce contexte, nous avons exploré la fonction de l’orthologue d’Ataxine-7 chez le poisson-zèbre au cours du développement de l’œil. L’inactivation d’atxn7 chez le poisson-zèbre – par des approches utilisant des oligonucléotides anti-sens ou par CRISPR/Cas9 – résulte principalement en un colobome, malformation structurelle de l’œil causée par un défaut de fermeture de la fissure choroïde. Les morphants atxn7 présentent une altération du motif proximo-distal de la vésicule optique causée par une élévation de la signalisation Hedgehog (Hh). Une étude minutieuse des photorécepteurs révèle un défaut de la morphogénèse des segments externes. La sensibilité de l’œil aux variations de fonction d’atxn7 pourrait expliquer la phyiopathologie SCA7. Notre étude suggère également qu’une perte de fonction d’atxn7 contribuerait au développement du colobome chez l’Homme. / Spinocerebellar ataxia type 7 (SCA7) is an autosomal-dominant neurodegenerative disorder caused by a toxic polyglutamine (polyQ) expansion in Ataxin-7 which leads to degeneration of cone and rod photoreceptors. The selective nature of degeneration remains unclear since Ataxin-7 is ubiquitously expressed. Here, we have explored the function of the Ataxin-7 ortholog in zebrafish during eye development. Inactivation of atxn7 in zebrafish primarily resulted in a coloboma defect, a structural malformation of the eye caused by failure of the choroid fissure to close. atxn7 morphants displayed altered proximo-distal patterning of the optic vesicle, caused by elevated Hedgehog (Hh) signaling. Careful examination of the photoreceptors reveals a defect in the morphogenesis of the outer segments. The eye sensitivity to variations in atxn7 function could account for SCA7 physiopathology. Our study also suggests that atxn7 loss of function may contribute to the development of human coloboma.

Le syndrome CHARGE est une maladie génétique rare dont l’acronyme désigne les principales anomalies initialement identifiées pour décrire ce syndrome : colobome, problèmes cardiaques, atrésie des choanes, retard mental et de développement, anomalies génitales et défauts aux oreilles. Les patients présentent des combinaisons hautement variables d’anomalies et ce même entre individus d’une même famille. La principale cause de ce syndrome est une mutation du gène CHD7, mais de nouveaux gènes dont la mutation peut également engendrer ce syndrome, tel FAM172A , ont récemment été identifiés. Le modèle murin Toupee porte une mutation dans le gène Fam172a et présente les principales caractéristiques du syndrome CHARGE. Fait intéressant, si FVBToupee présente dans une forte proportion le colobome oculaire, 55% des individus B6ToupeeTg/Tg et 16% des individus B6ToupeeTg/+ présentent de la microphtalmie et de l’anophtalmie. Ces anomalies oculaires ont tout d’abord été caractérisées. Les études menées ont notamment permis d’identifier que chez B6Toupee la microphtalmie et l’anophtalmie sont beaucoup plus fréquentes dans l’œil droit et qu’elles se déclinent en plusieurs degrés variables d’atteinte au globe oculaire. Par la suite, l’étude comparative des modèles ToupeeTg/Tg et Chd7Gt/+a été réalisée dans les fonds génétiques FVB et C57Bl/6. Des différences significatives de pénétrance de même que des divergences phénotypiques ont permis de déterminer que l’identité du gène à l’origine du syndrome CHARGE et que le fond génétique modulent tous deux le développement phénotypique du syndrome CHARGE. Finalement, l’étude de doubles hétérozygotes FVBToupeeTg/+ ;Chd7Gt/+ a permis de confirmer une interaction génétique modérée entre Fam172a et Chd7 tandis que l’investigation de la mortalité néonatale chez Chd7Gt/+ a permis de suspecter des problèmes d’alimentation. / CHARGE syndrome is a rare genetic disease for which the acronym stands for the main characteristics initially identified to describe the syndrome: coloboma, heart problems, choanal atresia, retarded growth and development, genital anomalies and ear defects. Patients present highly variable combinations of anomalies, even between members of the same family. The main cause of this syndrome is a mutation in the CHD7 gene, but new genes whose mutation can also give rise to this syndrome, such as FAM172A, were recently identified. The Fam172a gene is mutated in the Toupee mouse model, which presents the main characteristics of CHARGE syndrome. Interestingly, while FVBToupee animals present coloboma in a strong proportion, 55% of B6ToupeeTg/Tg individuals and 16% of B6ToupeeTg/+ individuals present microphthalmia and anophthalmia. First, detailed characterization of these ocular anomalies revealed that microphthalmia and anophthalmia are much more frequent in the right eye of B6Toupee mice, with varying degrees of severity. Then, comparative analysis of ToupeeTg/Tg and Chd7Gt/+models in FVB and C57Bl/6 genetic backgrounds further revealed significant differences in penetrance and phenotypic presentation, suggesting that the identity of the causative gene and the genetic background both modulate phenotypic outcome of CHARGE syndrome. Finally, characterization of FVBToupeeTg/+;Chd7Gt/+ double heterozygotes confirmed a moderate genetic interaction between Fam172a and Chd7 while investigations of Chd7Gt/+ neonatal mortality allowed to suspect feeding problems.